2025/08/25 更新

お知らせ

 

写真a

ヒサマツ ユウイチ
久松 雄一
HISAMATSU YUICHI
所属
九州大学病院 乳腺外科(2) 助教
医学部 医学科(併任)
職名
助教
連絡先
メールアドレス
電話番号
0926425466
プロフィール
平成16年3月に防衛医科大学校を卒業し、2年間の初期臨床研修を防衛医大病院および自衛隊中央病院で行った。初期臨床研修を終了した後に、2年間陸上自衛隊医官として札幌市真駒内駐屯地で勤務した。平成20年8月に九州大学第二外科に入局し、8か月間医員として勤務したのち、平成21年4月から大学院に進学した。大学院では主にホルモン受容体陽性乳癌に対するホルモン療法の感受性を予測するバイオマーカーを中心に研究を行って平成24年3月に医学博士号を取得した。その後臨床医として、大分県立病院で医員を1年間、続いて済生会唐津病院で同じく医員を5年間勤めた。この間に消化器外科医として研鑽を積み、外科専門、乳腺専門医、消化器外科専門医、癌治療認定医を取得した。平成30年から九州大学病院 第二外科にて3年間手術や化学療法、そして免疫療法を学び、令和3年から2年間九州大学病院別府病院にてさらに研鑽をつみ、消化器外科指導医、乳腺外科指導医を取得した。この経験、技術を患者さんに最適な医療を提供できるように心掛けている。 【学会活動】 日本外科学会・専門医 日本消化器外科学会・専門医・指導医 日本消化器外科学会・消化器がん外科治療認定医 日本乳癌学会・専門医                                                        日本がん治療認定医機構・がん治療認定医 臨床研修指導医 日本癌治療学会認定医
外部リンク

研究分野

  • ライフサイエンス / ゲノム生物学

学位

  • 医学博士 ( 2012年3月 九州大学 )

学歴

  • 防衛省 防衛医科大学校   医学部   医学科

    1998年4月 - 2004年3月

      詳細を見る

    国名:日本国

研究テーマ・研究キーワード

  • 研究テーマ: 乳癌のmicro RNA検出の意義

    研究キーワード: 乳癌

    研究期間: 2024年4月 - 2026年3月

  • 研究テーマ: 大腸癌早期発見における尿中micro RNA検出の意義

    研究キーワード: 尿中micro RNA, 大腸癌

    研究期間: 2021年8月 - 2026年3月

論文

  • Polo-Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations 査読 国際誌

    Tanaka, Y; Oki, E; Nakanishi, R; Kawazoe, T; Kudo, K; Zaitsu, Y; Hisamatsu, Y; Ando, K; Oda, Y; Yoshizumi, T

    CANCER SCIENCE   116 ( 7 )   2032 - 2039   2025年7月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/cas.70088

    Web of Science

    PubMed

  • A 14-Gene Panel for Predicting Colorectal Cancer Recurrence Using Circulating Tumor DNA in Different Testing Conditions 査読 国際誌

    Hisamatsu, Y; Ando, K; Kudo, K; Nakanishi, R; Kawazoe, T; Zaitsu, Y; Kusumoto, T; Hata, T; Kagawa, Y; Yoshizumi, T; Ashida, N; Niiro, H; Hirose, T; Oki, E

    CANCER SCIENCE   2025年6月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/cas.70114

    Web of Science

    PubMed

  • Squamous cell carcinoma arising in sacrococcygeal teratoma in an adult: A case report 査読 国際誌

    Tanaka, Y; Nakanishi, R; Hazama, H; Mori, T; Kawazoe, T; Kudou, K; Zaitsu, Y; Hisamatsu, Y; Ando, K; Oki, E; Aishima, S; Oda, Y; Yoshizumi, T

    HUMAN PATHOLOGY REPORTS   40   2025年6月   eISSN:2772-736X

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Human Pathology Reports  

    Sacrococcygeal teratomas (SCT) with malignant transformation to squamous cell carcinoma are extremely rare, with only few cases reported in the literature. Herein, we report on a case of a primary sacrococcygeal mature cystic teratoma with malignant transformation into a squamous cell carcinoma. A 53-year-old woman presented with dysuria and lower abdominal pain caused by a huge SCT. Computed tomography (CT), magnetic resonance imaging, and positron emission tomography/CT findings were suggestive of SCT with malignant transformation. The treatment involved robotic-assisted laparoscopic abdominoperineal resection and bilateral lymph node dissection. Histopathology revealed squamous cell carcinoma within the teratoma. Postoperatively, the patient underwent six cycles of paclitaxel-carboplatin chemotherapy and showed no signs of recurrence during the 1-year follow-up.

    DOI: 10.1016/j.hpr.2025.300773

    Web of Science

    Scopus

  • SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer 査読 国際誌

    Ando, Y; Masuda, T; Hayashi, N; Kosai, K; Shibuta, S; Ono, Y; Taro, T; Otsu, H; Hisamatsu, Y; Yoshizumi, T; Mimori, K

    BREAST CANCER   32 ( 3 )   457 - 469   2025年5月   ISSN:1340-6868 eISSN:1880-4233

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Breast Cancer  

    Background: The single-nucleotide polymorphism rs6507583 at the promoter of SET-binding protein 1 (SETBP1) was implicated in estrogen receptor (ER)-positive breast carcinogenesis. Here, we evaluated the clinical and biological relevance of SETBP1 expression in ER-positive breast cancer (BC). Methods: The associations between SETBP1 expression and clinical outcomes in BC patients were analyzed in independent cohorts. The localizations of SETBP1 expression in BC tissues were observed by immunohistochemical staining. Pathway analyses were conducted using TCGA dataset. In vitro proliferation assay, protein phosphatase 2A (PP2A) activity assay, and gene expression analysis were performed in SETBP1-knockdown ER-positive BC cells. We investigated the factors influencing SETBP1 mRNA expression using TCGA dataset. rs6507583 presence and SETBP1 mRNA expression in 11 mammary cell lines and 56 BC tissue samples were examined by target sequencing and RT-qPCR, respectively. Results: SETBP1 was downregulated in BC cells compared with normal ductal epithelial cells. Low SETBP1 mRNA expression was an independent prognostic factor for poor recurrence-free survival. Pathway analyses revealed an inverse relationship between decreased SETBP1 expression and the expression of E2F, MYC, and G2M checkpoint target genes in BC tissues. SETBP1 knockdown promoted proliferation, inhibition of PP2A activity, and phosphorylation of MAPK in ER-positive BC. Low SETBP1 expression was influenced by high SETBP1 promoter methylation and DNA copy number SETBP1 deletion. SETBP1 expression with rs6507583 was lower than without rs6507583 in BC. Conclusions: We demonstrated that low SETBP1 expression could be a poor prognostic biomarker that promotes ER-positive BC proliferation, possibly via phosphorylation of MAPK.

    DOI: 10.1007/s12282-025-01667-w

    Web of Science

    Scopus

    PubMed

  • <i>SHARPIN</i> is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression 査読 国際誌

    Nakano, Y; Masuda, T; Sakamoto, T; Tanaka, N; Tobo, T; Hashimoto, M; Tatsumi, T; Saito, H; Takahashi, J; Koike, K; Abe, T; Ando, Y; Ozato, Y; Hosoda, K; Hirose, K; Higuchi, S; Ikehara, T; Hisamatsu, Y; Toshima, T; Yonemura, Y; Ogino, T; Uemura, M; Eguchi, H; Doki, Y; Mimori, K

    INTERNATIONAL JOURNAL OF ONCOLOGY   65 ( 6 )   2024年12月   ISSN:1019-6439 eISSN:1791-2423

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:International Journal of Oncology  

    Colorectal cancer (CRC) is widely prevalent and represents a significant contributor to global cancer‑related mortality. There remains a pressing demand for advance‑ ments in CRC treatment modalities. The E3 ubiquitin ligase is a critical enzyme involved in modulating protein expression levels via posttranslational ubiquitin‑mediated proteolysis, and it is reportedly involved in the progression of various cancers, making it a target of recent interest in anticancer therapy. In the present study, using comprehensive expression analysis involving spatial transcriptomic analysis with single‑cell RNA sequencing in clinical CRC datasets, the ubiquitin‑associated protein Shank‑associated RH domain interactor (SHARPIN) was identified, located on amplified chromosome 8q, which could promote CRC progression. SHARPIN was found to be upregulated in tumor cells, with elevated expression observed in tumor tissues. This heightened expression of SHARPIN was positively associated with lymphatic invasion and served as an independent predictor of a poor prognosis in patients with CRC. In vitro and in vivo analyses using SHARPIN‑overexpressing or ‑knockout CRC cells revealed that SHARPIN overexpression upregulated MDM2, resulting in the downregulation of p53, while SHARPIN silencing or knockout downregulated MDM2, leading to p53 upregulation, which affects cell cycle progression, tumor cell apoptosis and tumor growth in CRC. Furthermore, SHARPIN was found to be overexpressed in several cancer types, exerting significant effects on survival outcomes. In conclusion, SHARPIN represents a newly identified novel gene with the potential to promote tumor growth following apoptosis inhibition and cell cycle progression in part by inhibiting p53 expression via MDM2 upregulation; therefore, SHARPIN represents a potential therapeutic target for CRC.

    DOI: 10.3892/ijo.2024.5701

    Web of Science

    Scopus

    PubMed

  • RAS mutant transverse colon cancer with multiple liver metastases achieving long-term disease-free survival with postoperative maintenance therapy with aflibercept plus FOLFIRI and four repeated radical resections: a case report 査読 国際誌

    Tanaka, Y; Nakanishi, R; Sato, S; Otake, A; Ryujin, K; Ikeda, S; Ebata, Y; Harima, T; Natsugoe, K; Yoshiyama, T; Shin, Y; Kawazoe, T; Kudo, K; Zaitsu, Y; Hisamatsu, Y; Ando, K; Nakashima, Y; Itoh, S; Oki, E; Oda, Y; Yoshizumi, T

    SURGICAL CASE REPORTS   10 ( 1 )   231   2024年10月   ISSN:2198-7793

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1186/s40792-024-02033-2

    Web of Science

    PubMed

  • Breast mucoepidermoid carcinoma with a rare CRTC3-MAML2 fusion 査読 国際誌

    Kawaguchi, K; Ijichi, H; Ueo, H; Hisamatsu, Y; Omori, S; Shigechi, T; Kawaguchi, K; Yamamoto, H; Oda, Y; Kubo, M; Yoshizumi, T

    INTERNATIONAL CANCER CONFERENCE JOURNAL   13 ( 4 )   481 - 487   2024年10月   ISSN:2192-3183

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s13691-024-00713-2

    Web of Science

    PubMed

  • Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer 査読 国際誌

    Hashimoto, M; Masuda, T; Nakano, Y; Tobo, T; Saito, H; Koike, K; Takahashi, J; Abe, T; Ando, Y; Ozato, Y; Hosoda, K; Higuchi, S; Hisamatsu, Y; Toshima, T; Yonemura, Y; Hata, T; Uemura, M; Eguchi, H; Doki, Y; Mori, M; Mimori, K

    CANCER SCIENCE   115 ( 6 )   1866 - 1880   2024年6月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Science  

    Bromodomain and extraterminal domain (BET) family proteins are epigenetic master regulators of gene expression via recognition of acetylated histones and recruitment of transcription factors and co-activators to chromatin. Hence, BET family proteins have emerged as promising therapeutic targets in cancer. In this study, we examined the functional role of bromodomain containing 3 (BRD3), a BET family protein, in colorectal cancer (CRC). In vitro and vivo analyses using BRD3-knockdown or BRD3-overexpressing CRC cells showed that BRD3 suppressed tumor growth and cell cycle G1/S transition and induced p21 expression. Clinical analysis of CRC datasets from our hospital or The Cancer Genome Atlas revealed that BET family genes, including BRD3, were overexpressed in tumor tissues. In immunohistochemical analyses, BRD3 was observed mainly in the nucleus of CRC cells. According to single-cell RNA sequencing in untreated CRC tissues, BRD3 was highly expressed in malignant epithelial cells, and cell cycle checkpoint-related pathways were enriched in the epithelial cells with high BRD3 expression. Spatial transcriptomic and single-cell RNA sequencing analyses of CRC tissues showed that BRD3 expression was positively associated with high p21 expression. Furthermore, overexpression of BRD3 combined with knockdown of, a driver gene in the BRD family, showed strong inhibition of CRC cells in vitro. In conclusion, we demonstrated a novel tumor suppressive role of BRD3 that inhibits tumor growth by cell cycle inhibition in part via induction of p21 expression. BRD3 activation might be a novel therapeutic approach for CRC.

    DOI: 10.1111/cas.16129

    Web of Science

    Scopus

    PubMed

  • Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer 査読 国際誌

    Nakano, T; Takao, S; Dairaku, K; Uno, N; Low, SK; Hashimoto, M; Tsuda, Y; Hisamatsu, Y; Toshima, T; Yonemura, Y; Masuda, T; Eto, K; Ikegami, T; Fukunaga, Y; Niida, A; Nagayama, S; Mimori, K

    CANCER SCIENCE   115 ( 6 )   1989 - 2001   2024年6月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Science  

    Considering the cost and invasiveness of monitoring postoperative minimal residual disease (MRD) of colorectal cancer (CRC) after adjuvant chemoradiotherapy (ACT), we developed a favorable approach based on methylated circulating tumor DNA to detect MRD after radical resection. Analyzing the public database, we identified the methylated promoter regions of the genes FGD5, GPC6, and MSC. Using digital polymerase chain reaction (dPCR), we termed the “amplicon of methylated sites using a specific enzyme” assay as “AMUSE.” We examined 180 and 114 pre- and postoperative serial plasma samples from 28 recurrent and 19 recurrence-free pathological stage III CRC patients, respectively. The results showed 22 AMUSE-positive of 28 recurrent patients (sensitivity, 78.6%) and 17 AMUSE-negative of 19 recurrence-free patients (specificity, 89.5%). AMUSE predicted recurrence 208 days before conventional diagnosis using radiological imaging. Regarding ACT evaluation by the reactive response, 19 AMUSE-positive patients during their second or third blood samples showed a significantly poorer prognosis than the other patients (p = 9E-04). The AMUSE assay stratified four groups by the altered patterns of tumor burden postoperatively. Interestingly, only 34.8% of cases tested AMUSE-negative during ACT treatment, indicating eligibility for ACT. The AMUSE assay addresses the clinical need for accurate MRD monitoring with universal applicability, minimal invasiveness, and cost-effectiveness, thereby enabling the timely detection of recurrences. This assay can effectively evaluate the efficacy of ACT in patients with stage III CRC following curative resection. Our study strongly recommends reevaluating the clinical application of ACT using the AMUSE assay.

    DOI: 10.1111/cas.16149

    Web of Science

    Scopus

    PubMed

  • Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis 査読 国際誌

    Hashimoto, M; Kojima, Y; Sakamoto, T; Ozato, Y; Nakano, Y; Abe, T; Hosoda, K; Saito, H; Higuchi, S; Hisamatsu, Y; Toshima, T; Yonemura, Y; Masuda, T; Hata, T; Nagayama, S; Kagawa, K; Goto, Y; Utou, M; Gamachi, A; Imamura, K; Kuze, Y; Zenkoh, J; Suzuki, A; Takahashi, K; Niida, A; Hirose, H; Hayashi, S; Koseki, J; Fukuchi, S; Murakami, K; Yoshizumi, T; Kadomatsu, K; Tobo, T; Oda, Y; Uemura, M; Eguchi, H; Doki, Y; Mori, M; Oshima, M; Shibata, T; Suzuki, Y; Shimamura, T; Mimori, K

    EBIOMEDICINE   103   105102   2024年5月   ISSN:2352-3964

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Ebiomedicine  

    Background: Cell–cell interaction factors that facilitate the progression of adenoma to sporadic colorectal cancer (CRC) remain unclear, thereby hindering patient survival. Methods: We performed spatial transcriptomics on five early CRC cases, which included adenoma and carcinoma, and one advanced CRC. To elucidate cell–cell interactions within the tumour microenvironment (TME), we investigated the colocalisation network at single-cell resolution using a deep generative model for colocalisation analysis, combined with a single-cell transcriptome, and assessed the clinical significance in CRC patients. Findings: CRC cells colocalised with regulatory T cells (Tregs) at the adenoma–carcinoma interface. At early-stage carcinogenesis, cell–cell interaction inference between colocalised adenoma and cancer epithelial cells and Tregs based on the spatial distribution of single cells highlighted midkine (MDK) as a prominent signalling molecule sent from tumour epithelial cells to Tregs. Interaction between MDK-high CRC cells and SPP1+ macrophages and stromal cells proved to be the mechanism underlying immunosuppression in the TME. Additionally, we identified syndecan4 (SDC4) as a receptor for MDK associated with Treg colocalisation. Finally, clinical analysis using CRC datasets indicated that increased MDK/SDC4 levels correlated with poor overall survival in CRC patients. Interpretation: MDK is involved in the immune tolerance shown by Tregs to tumour growth. MDK-mediated formation of the TME could be a potential target for early diagnosis and treatment of CRC. Funding: Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Science Research; OITA Cancer Research Foundation; AMED under Grant Number; Japan Science and Technology Agency (JST); Takeda Science Foundation; The Princess Takamatsu Cancer Research Fund.

    DOI: 10.1016/j.ebiom.2024.105102

    Web of Science

    Scopus

    PubMed

  • Field experiment of a telesurgery system using a surgical robot with haptic feedback 査読 国際誌

    Ota, M; Oki, E; Nakanoko, T; Tanaka, Y; Toyota, S; Hu, QJ; Nakaji, Y; Nakanishi, R; Ando, K; Kimura, Y; Hisamatsu, Y; Mimori, K; Takahashi, Y; Morohashi, H; Kanno, T; Tadano, K; Kawashima, K; Takano, H; Ebihara, Y; Shiota, M; Inokuchi, J; Eto, M; Yoshizumi, T; Hakamada, K; Hirano, S; Mori, M

    SURGERY TODAY   54 ( 4 )   375 - 381   2024年4月   ISSN:0941-1291 eISSN:1436-2813

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Surgery Today  

    Purpose: To verify the usefulness of haptic feedback in telesurgery and improve the safety of telerobotic surgery. Methods: The surgeon's console was installed at two sites (Fukuoka and Beppu; 140 km apart), and the patient cart was installed in Fukuoka. During the experiment, the surgeon was blinded to the haptic feedback levels and asked to grasp the intestinal tract in an animal model. The surgeon then performed the tasks at each location. Results: No marked differences in task accuracy or average grasping force were observed between the surgeon locations. However, the average task completion time was significantly longer, and the system usability scale (SUS) was significantly lower rating for remote operations than for local ones. No marked differences in task accuracy or task completion time were observed between the haptic feedback levels. However, with haptic feedback, the organ was grasped with a significantly weaker force than that without it. Furthermore, with haptic feedback, experienced surgeons in robotic surgery tended to perform an equivalent task with weaker grasping forces than inexperienced surgeons. Conclusion: The haptic feedback function is a tool that allows the surgeon to perform surgery with an appropriate grasping force, both on site and remotely. Improved safety is necessary in telesurgery; haptic feedback will thus be an essential technology in robotic telesurgery going forward.

    DOI: 10.1007/s00595-023-02732-7

    Web of Science

    Scopus

    PubMed

  • The significance of epigenetic regulator BRD3 in colorectal cancer progression 査読 国際誌

    Hashimoto, M; Masuda, T; Nakano, Y; Hosoda, K; Abe, T; Ando, Y; Hirose, K; Hisamatsu, Y; Toshima, T; Yonemura, Y; Uemura, M; Eguchi, H; Doki, Y; Mimori, K

    CANCER SCIENCE   115   613 - 613   2024年3月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Rab27b, a regulator of exosome secretion, is associated with peritoneal metastases in gastric cancer 査読 国際誌

    Masuda, T; Nambara, S; Hu, QJ; Ozato, Y; Hirose, K; Hiraki, Y; Hisamatsu, Y; Mimori, K

    CANCER SCIENCE   115   141 - 141   2024年3月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • A rare case of liver regenerative and non-neoplastic lesion resembling a well-differentiated hepatocellular carcinoma 査読 国際誌

    Hirose, K; Toshima, T; Tobo, T; Kai, S; Hirakawa, M; Higuchi, S; Ofuchi, T; Hosoda, K; Yonemura, Y; Hisamatsu, Y; Masuda, T; Aishima, S; Mimori, K

    SURGICAL CASE REPORTS   10 ( 1 )   30   2024年2月   ISSN:2198-7793

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1186/s40792-024-01820-1

    Web of Science

    PubMed

  • Real-time telementoring with 3D drawing annotation in robotic surgery 査読 国際誌

    Nakanoko, T; Oki, E; Ota, M; Ikenaga, N; Hisamatsu, Y; Toshima, T; Kanno, T; Tadano, K; Kawashima, K; Ohuchida, K; Morohashi, H; Ebihara, Y; Mimori, K; Nakamura, M; Yoshizumi, T; Hakamada, K; Hirano, S; Ikeda, N; Mori, M

    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES   37 ( 12 )   9676 - 9683   2023年12月   ISSN:0930-2794 eISSN:1432-2218

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Surgical Endoscopy  

    Background: In telementoring, differences in teaching methods affect local surgeons’ comprehension. Because the object to be operated on is a three-dimensional (3D) structure, voice or 2D annotation may not be sufficient to convey the instructor’s intention. In this study, we examined the usefulness of telementoring using 3D drawing annotations in robotic surgery. Methods: Kyushu University and Beppu Hospital are located 140 km apart, and the study was conducted using a Saroa™ surgical robot by RIVERFIELD Inc. using a commercial guarantee network on optical fiber. Twenty medical students performed vertical mattress suturing using a swine intestinal tract under surgical guidance at the Center for Advanced Medical Innovation Kyushu University. Surgical guidance was provided by Beppu Hospital using voice, 2D, and 3D drawing annotations. All robot operations were performed using 3D images, and only the annotations were independently switched between voice and 2D and 3D images. The operation time, needle movement, and performance were also evaluated. Results: The 3D annotation group tended to have a shorter working time than the control group (25.6 ± 63.2 vs. − 36.7 ± 65.4 min, P = 0.06). The 3D annotation group had fewer retries than the control group (1.3 ± 1.7 vs. − 1.1 ± 0.7, P = 0.006), and there was a tendency for fewer needle drops (0.4 ± 0.7 vs. − 0.5 ± 0.9, P = 0.06). The 3D annotation group scored significantly higher than the control group on the Global Evaluate Assessment of Robot Skills (16.8 ± 2.0 vs. 22.8 ± 2.4, P = 0.04). The 3D annotation group also scored higher than the voice (13.4 ± 1.2) and 2D annotation (16.2 ± 1.8) groups (3D vs. voice: P = 0.03, 3D vs. 2D: P = 0.03). Conclusion: Telementoring using 3D drawing annotation was shown to provide good comprehension and a smooth operation for local surgeons. Graphical abstract: [Figure not available: see fulltext.]

    DOI: 10.1007/s00464-023-10521-z

    Web of Science

    Scopus

    PubMed

  • Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers 査読 国際誌

    Kobayashi, Y; Niida, A; Nagayama, S; Saeki, K; Haeno, H; Takahashi, KK; Hayashi, S; Ozato, Y; Saito, H; Hasegawa, T; Nakamura, H; Tobo, T; Kitagawa, A; Sato, K; Shimizu, D; Hirata, H; Hisamatsu, Y; Toshima, T; Yonemura, Y; Masuda, T; Mizuno, S; Kawazu, M; Kohsaka, S; Ueno, T; Mano, H; Ishihara, S; Uemura, M; Mori, M; Doki, Y; Eguchi, H; Oshima, M; Suzuki, Y; Shibata, T; Mimori, K

    BRITISH JOURNAL OF CANCER   129 ( 7 )   1105 - 1118   2023年10月   ISSN:0007-0920 eISSN:1532-1827

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:British Journal of Cancer  

    Background: Intratumor heterogeneity (ITH) in microsatellite instability-high (MSI-H) colorectal cancer (CRC) has been poorly studied. We aimed to clarify how the ITH of MSI-H CRCs is generated in cancer evolution and how immune selective pressure affects ITH. Methods: We reanalyzed public whole-exome sequencing data on 246 MSI-H CRCs. In addition, we performed a multi-region analysis from 6 MSI-H CRCs. To verify the process of subclonal immune escape accumulation, a novel computational model of cancer evolution under immune pressure was developed. Results: Our analysis presented the enrichment of functional genomic alterations in antigen-presentation machinery (APM). Associative analysis of neoantigens indicated the generation of immune escape mechanisms via HLA alterations. Multiregion analysis revealed the clonal acquisition of driver mutations and subclonal accumulation of APM defects in MSI-H CRCs. Examination of variant allele frequencies demonstrated that subclonal mutations tend to be subjected to selective sweep. Computational simulations of tumour progression with the interaction of immune cells successfully verified the subclonal accumulation of immune escape mutations and suggested the efficacy of early initiation of an immune checkpoint inhibitor (ICI) -based treatment. Conclusions: Our results demonstrate the heterogeneous acquisition of immune escape mechanisms in MSI-H CRCs by Darwinian selection, providing novel insights into ICI-based treatment strategies.

    DOI: 10.1038/s41416-023-02395-8

    Web of Science

    Scopus

    PubMed

  • Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence 査読 国際誌

    Hosoda, K; Toshima, T; Takahashi, J; Yonemura, Y; Hisamatsu, Y; Hirose, K; Masuda, T; Motomura, Y; Abe, T; Ando, Y; Dairaku, K; Nakano, Y; Hashimoto, M; Hiraki, Y; Soejima, Y; Yoshizumi, T; Mimori, K

    INTERNATIONAL CANCER CONFERENCE JOURNAL   12 ( 4 )   274 - 278   2023年10月   ISSN:2192-3183

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s13691-023-00618-6

    Web of Science

    PubMed

  • Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations 査読 国際誌

    Oki, E; Ota, M; Nakanoko, T; Tanaka, Y; Toyota, S; Hu, QJ; Nakaji, Y; Nakanishi, R; Ando, K; Kimura, Y; Hisamatsu, Y; Mimori, K; Takahashi, Y; Morohashi, H; Kanno, T; Tadano, K; Kawashima, K; Takano, H; Ebihara, Y; Shiota, M; Inokuchi, J; Eto, M; Yoshizumi, T; Hakamada, K; Hirano, S; Mori, M

    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES   37 ( 8 )   6071 - 6078   2023年5月   ISSN:0930-2794 eISSN:1432-2218

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Surgical Endoscopy  

    Background: Although several studies on telesurgery have been reported globally, a clinically applicable technique has not yet been developed. As part of a telesurgical study series conducted by the Japan Surgical Society, this study describes the first application of a double-surgeon cockpit system to telesurgery. Methods: Surgeon cockpits were installed at a local site and a remote site 140 km away. Three healthy pigs weighing between 26 and 29 kg were selected for surgery. Non-specialized surgeons performed emergency hemostasis, cholecystectomy, and renal vein ligation with remote assistance using the double-surgeon cockpits and specialized surgeons performed actual telesurgery. Additionally, the impact of adding internet protocol security (IPsec) encryption to the internet protocol-virtual private network (IP-VPN) line on communication was evaluated to address clinical security concerns. Results: The average time required for remote emergency hemostasis with the double-surgeon cockpit system was 10.64 s. A non-specialized surgeon could safely perform cholecystectomy or renal vein ligation with remote assistance. Global Evaluative Assessment of Robotic Skills and System Usability Scale scores were higher for telesurgical support-assisted surgery by a non-specialized surgeon using the double-surgeon cockpits than for telesurgery performed by a specialized surgeon without the double-cockpit system. Adding IPsec encryption to the IP-VPN did not have a significant impact on communication. Conclusion: Telesurgical support through our double-surgeon cockpit system is feasible as first step toward clinical telesurgery.

    DOI: 10.1007/s00464-023-10061-6

    Web of Science

    Scopus

    PubMed

  • Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer 査読 国際誌

    Masuda, T; Ueo, H; Okumura, Y; Kai, YCR; Ando, Y; Masuguchi, K; Kitagawa, M; Kitagawa, A; Hayashi, N; Tsuruda, Y; Hisamatsu, Y; Suehiro, S; Ohmura, H; Fujiyoshi, K; Tanaka, F; Mimori, K

    CANCER GENOMICS & PROTEOMICS   20 ( 2 )   182 - 194   2023年3月   ISSN:1109-6535 eISSN:1790-6245

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Genomics and Proteomics  

    Background/Aim: The immune system has a pivotal role in modulating the response to chemotherapy in breast cancer (BC). However, the immune status during chemotherapy remains unclear. We evaluated the sequential changes in peripheral systemic immunity markers in BC patients treated with various chemotherapeutic agents. Materials and Methods: We examined the correlation between the peripheral systemic immunity markers, neutrophil-to-lymphocyte ratio (NLR), absolute lymphocyte count (ALC) and the local cytolytic activity (CYT) score obtained by quantitative reverse-transcription polymerase chain reaction of 84 preoperative BC patients. Next, we observed the sequential changes in the peripheral systemic immunity markers during treatment with four anticancer drugs: oral 5-fluorouracil derivative; S-1, epirubicin plus cyclophosphamide; paclitaxel plus the anti-vascular endothelial growth factor antibody bevacizumab, and eribulin in 172 HER2-negative advanced BC patients. Finally, we examined the correlation between the changes in the peripheral systemic immunity markers, time to treatment failure (TTF) and progression-free survival (PFS). Results: A negative correlation was found between ALC and NLR. ALC-low and NLR-high cases were positively associated with CYT score-low cases. The ratio of ALC-increase and NLR-decrease varies depending on the anticancer drugs used. The responder group (TTF .3 months) had a higher NLR-decrease ratio than the nonresponder group (TTF <3 months). Patients with a high NLR-decrease ratio showed higher PFS. Conclusion: The change in ALC or NLR varies according to the anticancer drugs, suggesting differential immunomodulatory effects of the drugs. Furthermore, the change in NLR reflects the therapeutic efficacy of chemotherapy in advanced BC.

    DOI: 10.21873/cgp.20373

    Web of Science

    Scopus

    PubMed

  • 日本における虫垂goblet cell adenocarcinomaの臨床病理学的特徴 多施設共同後向き研究(Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study) 査読 国際誌

    Shiota Tetsuya, Murata Kohei, Kishimoto Mitsuo, Yao Takashi, Noura Shingo, Morita Shunji, Akiyoshi Takashi, Okamura Shu, Imasato Mitsunobu, Furuhata Tomohisa, Suto Takeshi, Takemasa Ichiro, Shingai Tatsushi, Ueda Masami, Mizuno Hitoshi, Hisamatsu Yuichi, Takeda Takashi, Fujii Makoto, Kagawa Yoshinori, Sugihara Kenichi, the Study Group of Appendiceal Neoplasms from the Japan Society of Colorectal Cancer Research Group

    Surgery Today   53 ( 2 )   174 - 181   2023年2月   ISSN:0941-1291

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:シュプリンガー・ジャパン(株)  

    日本人虫垂杯細胞腺癌(GCA)患者の臨床的特徴について検討した。2000年1月~2017年12月に、日本の43施設で治療した虫垂腫瘍患者922例を後向き研究に登録した。このうち組織学的に虫垂杯細胞カルチノイド(GCC)と診断された患者32例(3.5%)の組織標本を虫垂GCAの新規評価基準で診断し、最終的に20例を対象に解析した。その結果、5年生存率は61.4%、生存期間中央値は93.1ヵ月であった。腹膜播種と有意に関連のある因子は局所リンパ節転移で、関連する可能性のある因子はグレード3であった。T1/2の患者(2例)とグレード1の患者(4例)に腹膜播種は認められず、局所リンパ節転移の有意な関連因子は検出されなかった。2019年に改定されたWHO分類のgrading systemとの有意な関連性は認められなかった。

  • Tumor necrosis factor superfamily member 4 is a candidate driver gene for hepatocellular carcinoma 査読 国際誌

    Hosoda, K; Masuda, T; Saito, H; Ando, Y; Abe, T; Dairaku, K; Nakano, Y; Hashimoto, M; Hiraki, Y; Yonemura, Y; Toshima, T; Hisamatsu, Y; Takahashi, J; Soejima, Y; Mimori, K

    CANCER SCIENCE   114   2051 - 2051   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Transducin beta-like 2 (TBL2) on chromosome 7 is a candidate driver gene of lung adenocarcinoma (LUAD) 査読 国際誌

    Ono, Y; Masuda, T; Kosai, K; Shibuta, S; Miyata, Y; Ando, Y; Motomura, Y; Abe, T; Takahashi, J; Hisamatsu, Y; Toshima, T; Yonemura, Y; Takenaka, T; Yoshizumi, T; Mimori, K

    CANCER SCIENCE   114   1843 - 1843   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Identification of SHARPIN, a novel candidate driver gene of colorectal cancer, and its clinical significance 査読 国際誌

    Nakano, Y; Masuda, T; Hisamatsu, Y; Toshima, T; Yonemura, Y; Uemura, M; Eguchi, H; Doki, Y; Mimori, K

    CANCER SCIENCE   114   785 - 785   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Identification of candidate driver gene C3orf1 by chromosome copy number analysis in ESCC 査読 国際誌

    Hiraki, Y; Masuda, T; Motomura, Y; Dairaku, K; Mochizuki, K; Abe, T; Ando, Y; Takahashi, J; Nakano, Y; Hashimoto, M; Hosoda, K; Hisamatsu, Y; Toshima, T; Yonemura, Y; Mimori, K

    CANCER SCIENCE   114   2050 - 2050   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study 査読 国際誌

    Shiota, T; Murata, K; Kishimoto, M; Yao, T; Noura, S; Morita, S; Akiyoshi, T; Okamura, S; Imasato, M; Furuhata, T; Suto, T; Takemasa, I; Shingai, T; Ueda, M; Mizuno, H; Hisamatsu, Y; Takeda, T; Fujii, M; Kagawa, Y; Sugihara, K

    SURGERY TODAY   53 ( 2 )   174 - 181   2023年2月   ISSN:0941-1291 eISSN:1436-2813

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Surgery Today  

    Purpose: In the 5th edition of the World Health Organization classification, appendiceal goblet cell adenocarcinoma (GCA) is categorized separately from neuroendocrine tumors and other appendiceal adenocarcinomas. We clarified the clinicopathological characteristics of Japanese appendiceal GCA. Methods: We designed a retrospective multicenter cohort study and retrieved the data of patients with appendiceal neoplasms and histologically diagnosed appendiceal goblet cell carcinoid (GCC) treated from January 2000 to December 2017 in Japan. The available GCC slides were reviewed and diagnosed with a new grading system of GCA. Results: A total of 922 patients from 43 institutions were enrolled; of these, 32 cases were patients with GCC (3.5%), and 20 cases were ultimately analyzed. The 5-year survival rate was 61.4% (95% confidence interval: 27.4–83.2), and the median survival time was 93.1 months. For peritoneal metastasis, regional lymph node metastasis was a significant factor (p = 0.04), and Grade 3 was a potential factor (p = 0.07). No peritoneal metastasis was observed in either T1/2 patients (n = 2) or Grade 1 patients (n = 4). We were unable to detect any significant factors associated with regional lymph node metastasis. Conclusion: For peritoneal metastasis, regional lymph node metastasis was a significant factor, and Grade 3 was a potential factor.

    DOI: 10.1007/s00595-022-02562-z

    Web of Science

    Scopus

    PubMed

  • Dynamic changes in peripheral systemic immunity markers during various chemotherapies in advanced breast cancer 査読 国際誌

    Masuda, T; Ando, Y; Motomura, Y; Abe, T; Hashimoto, M; Nakano, Y; Dairaku, K; Hiraki, Y; Hosoda, K; Takahashi, J; Hisamatsu, Y; Toshima, T; Yonemura, Y; Mimori, K

    CANCER SCIENCE   114   2151 - 2151   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Exosome promotes peritoneal metastasis in gastric cancer 査読 国際誌

    Shibuta, S; Masuda, T; Nanbara, S; Takahashi, J; Hisamatsu, Y; Toshima, T; Yonemura, Y; Yoshizumi, T; Mimori, K

    CANCER SCIENCE   114   1368 - 1368   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Genomic characterizations of Japanese breast cancer 査読 国際誌

    Ando, Y; Masuda, T; Hosoda, K; Hashimoto, M; Nakano, Y; Dairaku, K; Mochizuki, K; Abe, T; Hiraki, Y; Motomura, Y; Takahashi, J; Hisamatsu, Y; Toshima, T; Yonemura, Y; Mimori, K

    CANCER SCIENCE   114   2162 - 2162   2023年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G plus cancer cells and SPP1+macrophages in colorectal cancer 査読 国際誌

    Ozato, Y; Kojima, Y; Kobayashi, Y; Hisamatsu, Y; Toshima, T; Yonemura, Y; Masuda, T; Kagawa, K; Goto, Y; Utou, M; Fukunaga, M; Gamachi, A; Imamura, K; Kuze, Y; Zenkoh, J; Suzuki, A; Niida, A; Hirose, H; Hayashi, S; Koseki, J; Oki, E; Fukuchi, S; Murakami, K; Tobo, T; Nagayama, S; Uemura, M; Sakamoto, T; Oshima, M; Doki, Y; Eguchi, H; Mori, M; Iwasaki, T; Oda, Y; Shibata, T; Suzuki, Y; Shimamura, T; Mimori, K

    CELL REPORTS   42 ( 1 )   111929   2023年1月   ISSN:2211-1247

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cell Reports  

    The cellular interactions in the tumor microenvironment of colorectal cancer (CRC) are poorly understood, hindering patient treatment. In the current study, we investigate whether events occurring at the invasion front are of particular importance for CRC treatment strategies. To this end, we analyze CRC tissues by combining spatial transcriptomics from patients with a public single-cell transcriptomic atlas to determine cell-cell interactions at the invasion front. We show that CRC cells are localized specifically at the invasion front. These cells induce human leukocyte antigen G (HLA-G) to produce secreted phosphoprotein 1 (SPP1)+ macrophages while conferring CRC cells with anti-tumor immunity, as well as proliferative and invasive properties. Taken together, these findings highlight the signaling between CRC cell populations and stromal cell populations at the cellular level.

    DOI: 10.1016/j.celrep.2022.111929

    Web of Science

    Scopus

    PubMed

  • Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer 査読 国際誌

    Nambara, S; Masuda, T; Hirose, K; Hu, QJ; Tobo, T; Ozato, Y; Kurashige, J; Hiraki, Y; Hisamatsu, Y; Iguchi, T; Sugimachi, K; Oki, E; Yoshizumi, T; Mimori, K

    CANCER GENOMICS & PROTEOMICS   20 ( 1 )   30 - 39   2023年1月   ISSN:1109-6535 eISSN:1790-6245

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Genomics and Proteomics  

    Background/Aim: Peritoneal metastasis (PM) of gastric cancer (GC) leads to poor clinical outcomes. Tumor-derived exosomes promote metastasis via communication between tumor cells and host cells. In this study, we investigated the effect of Rab27, which is required for exosome secretion, on the PM of GC. Materials and Methods: We established a stable knockdown of two Rab27 homologs, Rab27a and Rab27b, in human GC cells (58As9) with a high potential of PM. We examined the level of exosome secretion from Rab27-knockdown 58As9 cells by Western blotting and the ability of Rab27b knockdown to suppress PM in 58As9 cells using a mouse xenograft model. In vitro proliferation and invasion assays were performed in the Rab27b-knockdown cells. Next, Rab27b expression was evaluated in human GC tissues by immunohistochemistry. Finally, we assessed the clinicopathological and prognostic significance of Rab27b expression by RT-qPCR in both our and other TCGA datasets of GC. Results: Rab27a and Rab27b knockdown in 58As9 cells decreased the secretion of exosomes, characterized by the endocytic marker CD63.

    DOI: 10.21873/cgp.20362

    Web of Science

    Scopus

    PubMed

  • Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer 査読 国際誌

    Otsu, H; Nambara, S; Hu, QJ; Hisamatsu, Y; Toshima, T; Takeishi, K; Yonemura, Y; Masuda, T; Oki, E; Mimori, K

    ANNALS OF GASTROENTEROLOGICAL SURGERY   7 ( 1 )   63 - 70   2023年1月   ISSN:2475-0328

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Annals of Gastroenterological Surgery  

    Aim: Gastric mucosal changes associated with chronic gastritis are known to be precancerous lesions of gastric cancer. We aimed to identify individuals with a high risk of gastric cancer by detection of microRNAs (miRNA) in the blood as biomarkers. Methods: Of 1206 individuals screened, 144 who were positive for Helicobacter pylori (H. pylori) by the serum antibody test and who underwent endoscopy were the subjects of this study. For the gross assessment of mucosal inflammation, we applied the Kimura–Takemoto classification, in which normal mucosa was defined as grade 0, and atrophy was categorized as grade 1 (C-1 and C-2), grade 2 (C-3 and O-1), and grade 3 (O-2 and O-3). Serum samples were divided into two phases and used for miRNA microarray profiling. We compared the expression of miRNAs in grade 3 mucosa and other grades. Expression in gastric cancer was confirmed with TCGA data. Results: miR-196b-3p was significantly upregulated, and miR-92a-2-5p was downregulated (P <.05 and q < 0.2). TCGA data showed a high expression of miR-196b-3p in gastric cancer cases (P <.001). Comparing grade 3 and the others, the area under the receiver operating characteristic curve using the detected miRNAs was as high as about 0.7. Furthermore, the combination of miRNAs resulted in higher accuracy. In terms of the significance of the combinatory mRNAs, the combination of three miRNAs (miR-196b-3p, miR-92a-2-5p, and miR-6791-3p) revealed high sensitivity and specificity, with the area under the curve exceeding 0.8. Conclusion: The identified combinatory miRNAs may represent promising biomarkers of precancerous lesions in gastric cancer.

    DOI: 10.1002/ags3.12610

    Web of Science

    Scopus

    PubMed

  • Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer 査読 国際誌

    Mochizuki, K; Kudo, S; Kato, K; Kudo, K; Ogawa, Y; Kouyama, Y; Takashina, Y; Ichimasa, K; Tobo, T; Toshima, T; Hisamatsu, Y; Yonemura, Y; Masuda, T; Miyachi, H; Ishida, F; Nemoto, T; Mimori, K

    PLOS ONE   17 ( 10 )   e0273566   2022年10月   eISSN:1932-6203

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Plos One  

    Background Colorectal cancer (CRC) can be classified into four consensus molecular subtypes (CMS) according to genomic aberrations and gene expression profiles. CMS is expected to be useful in predicting prognosis and selecting chemotherapy regimens. However, there are still no reports on the relationship between the morphology and CMS. Methods This retrospective study included 55 subjects with T2 CRC undergoing surgical resection, of whom 30 had the depressed type and 25 the protruded type. In the classification of the CMS, we first defined cases with deficient mismatch repair as CMS1. And then, CMS2/3 and CMS4 were classified using an online classifier developed by Trinh et al. The staining intensity of CDX2, HTR2B, FRMD6, ZEB1, and KER and the percentage contents of CDX2, FRMD6, and KER are input into the classifier to obtain automatic output classifying the specimen as CMS2/3 or CMS4. Results According to the results yielded by the online classifier, of the 30 depressed-type cases, 15 (50%) were classified as CMS2/3 and 15 (50%) as CMS4. Of the 25 protruded-type cases, 3 (12%) were classified as CMS1 and 22 (88%) as CMS2/3. All of the T2 CRCs classified as CMS4 were depressed CRCs. More malignant pathological findings such as lymphatic invasion were associated with the depressed rather than protruded T2 CRC cases. Conclusions Depressed-type T2 CRC had a significant association with CMS4, showing more malignant pathological findings such as lymphatic invasion than the protruded-type, which could explain the reported association between CMS4 CRC and poor prognosis.

    DOI: 10.1371/journal.pone.0273566

    Web of Science

    Scopus

    PubMed

  • Influence of Robotic Rectal Resection Versus Laparoscopic Rectal Resection on Postoperative Ileus: A Single-center Experience 査読 国際誌

    Hu, QJ; Oki, E; Fujimoto, Y; Jogo, T; Hokonohara, K; Nakanishi, R; Hisamatsu, Y; Ando, K; Kimura, Y; Mori, M

    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES   32 ( 4 )   425 - 430   2022年8月   ISSN:1530-4515 eISSN:1534-4908

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Surgical Laparoscopy Endoscopy and Percutaneous Techniques  

    Aim: This study was performed to clarify the relationship between robotic rectal resection and postoperative ileus (POI) by comparing robotic surgery with laparoscopic surgery. Materials and Methods: We retrospectively reviewed 238 patients who underwent robotic (n=41) or laparoscopic (n=197) rectal resection for rectal cancer in our institution from January 2013 to June 2020. First, we compared the background factors and short-term surgical outcomes between robotic and laparoscopic surgery. Next, we investigated the postoperative complications of robotic and laparoscopic rectal resection. Finally, we identified the risk factors for POI following rectal cancer resection. Results: The percentages of patients with an Rb tumor location, treatment by abdominoperitoneal resection/intersphincteric resection/low anterior resection, a temporary diverting ileostomy, and a long operation time were significantly higher in robotic than laparoscopic surgery (P<0.0001, P=0.0002, P=0.0078, and P=0.0001, respectively). There was no significant difference in any individual postoperative complication between robotic and laparoscopic surgery. Risk factors for POI were male sex (P=0.0078), neoadjuvant chemoradiotherapy (P=0.0007), an Rb tumor location (P=0.0005), treatment by abdominoperitoneal resection/intersphincteric resection/low anterior resection (P=0.0044), a temporary diverting ileostomy (P<0.0001), and operation time of ≥240 minutes (P=0.0024). Notably, robotic surgery was not a risk factor for POI following rectal resection relative to laparoscopic surgery. Conclusion: Although patients who underwent robotic surgery had more risk factors for POI, the risk of POI was similar between robotic and laparoscopic rectal resection.

    DOI: 10.1097/SLE.0000000000001056

    Web of Science

    Scopus

    PubMed

  • Characteristics of anal canal cancer in Japan 査読 国際誌

    Yamada, K; Saiki, Y; Komori, K; Shiomi, A; Ueno, M; Ito, M; Hida, K; Yamamoto, S; Shiozawa, M; Ishihara, S; Kanemitsu, Y; Ueno, H; Kinjo, T; Maeda, K; Kawamura, J; Fujita, F; Takahashi, K; Mizushima, T; Shimada, Y; Sasaki, S; Sunami, E; Ishida, F; Hirata, K; Ohnuma, S; Funahashi, K; Watanabe, J; Kinugasa, Y; Yamaguchi, S; Hashiguchi, Y; Ikeda, M; Sudo, T; Komatsu, Y; Koda, K; Sakamoto, K; Okajima, M; Ishida, H; Hisamatsu, Y; Masuda, T; Mori, S; Minami, K; Hasegawa, S; Endo, S; Iwashita, A; Hamada, M; Ajioka, Y; Usuku, K; Ikeda, T; Sugihara, K

    CANCER MEDICINE   11 ( 14 )   2735 - 2743   2022年7月   ISSN:2045-7634

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Medicine  

    Anal canal cancer (ACC) has been reported to be an uncommon cancer in Japan, as in the USA, Europe, and Australia. This retrospective multi-institutional study was conducted to clarify the characteristics of ACC in Japan. First, the histological ACC type cases treated between 1991 and 2015 were collected. A detailed analysis of the characteristics of anal canal squamous cell carcinoma (SCC) cases was then conducted. The results of the histological types revealed that of the 1781 ACC cases, 435 cases (24.4%) including seven cases of adenosquamous cell carcinomas were SCC and 1260 cases (70.7%) were adenocarcinoma. However, the most common histological type reported in the USA, Europe, and Australia is SCC. Most ACC cases are adenocarcinomas and there is a low incidence of SCC in Japan which is different from the above-mentioned countries. Moreover, we reclassified T4 into the following two groups based on tumor size: T4a (tumor diameter of 5 cm or less) and T4b (tumor diameter of more than 5 cm). The results of the TNM classification of SCC revealed that the hazard ratio (HR) to T1 of T2, T3, T4a, and T4b was 2.45, 2.28, 2.89, and 4.97, respectively. As T4b cases had a worse prognosis than T4a cases, we propose that T4 for anal canal SCC in Japan be subclassified into T4a and T4b.

    DOI: 10.1002/cam4.4631

    Web of Science

    Scopus

    PubMed

  • 直腸癌手術において三層サーキュラーステープラーが吻合部漏の減少に及ぼす臨床的影響 ブタモデルと多施設後ろ向きコホート解析(Clinical impact of the triple-layered circular stapler for reducing the anastomotic leakage in rectal cancer surgery: Porcine model and multicenter retrospective cohort analysis) 査読 国際誌

    Nakanishi Ryota, Fujimoto Yoshiaki, Sugiyama Masahiko, Hisamatsu Yuichi, Nakanoko Tomonori, Ando Koji, Ota Mitsuhiko, Kimura Yasue, Oki Eiji, Yoshizumi Tomoharu

    Annals of Gastroenterological Surgery   6 ( 2 )   256 - 264   2022年3月

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:John Wiley & Sons Australia, Ltd  

    直腸癌手術後に生じる吻合部漏に対する三層サーキュラーステープラーと二層サーキュラーステープラーの有効性を比較検討した。ブタ回結腸吻合部における三層サーキュラーステープラーと二層サーキュラーステープラーの破裂圧を比較した。さらに、直腸癌に対して大腸吻合術を施行された194例を対象とする多施設後ろ向きコホート研究を実施して重度吻合部漏の術後発症率を評価した。二層サーキュラーステープラー使用群(EEA群)が153例(男性84例、女性69例、中央値66歳)、三層サーキュラーステープラー使用群(tri-EEA群)が41例(男性23例、女性18例、中央値67歳)であった。ブタを用いた実験での破裂圧は三層サーキュラーステープラーが26.4±6.2mmHg、二層サーキュラーステープラーが14.5±4.3mmHgと三層の方が有意に高値を示していた。臨床研究ではtri-EEA群の方がEEA群と比較して手術時間は有意に長く、術後在院期間と術後合併症の発症率に関してtri-EEA群とEEA群との間に有意差はみられなかったが、グレード3以上の吻合部漏の発症率はtri-EEA群の方が有意に低かった(0.0% vs 5.8%)。多変量解析ではtri-EEAの施行が吻合部漏の非発症を示す独立関連因子として抽出された。

  • Clinical impact of the triple-layered circular stapler for reducing the anastomotic leakage in rectal cancer surgery: Porcine model and multicenter retrospective cohort analysis 査読 国際誌

    Nakanishi, R; Fujimoto, Y; Sugiyama, M; Hisamatsu, Y; Nakanoko, T; Ando, K; Ota, M; Kimura, Y; Oki, E; Yoshizumi, T

    ANNALS OF GASTROENTEROLOGICAL SURGERY   6 ( 2 )   256 - 264   2022年3月   ISSN:2475-0328

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Annals of Gastroenterological Surgery  

    Aim: To investigate the impact of the triple-layered circular stapler compared with the double-layered circular stapler on anastomotic leakage after rectal cancer surgery. Methods: The bursting pressure was compared between porcine ileocolic anastomoses created using a double- or triple-layered stapler. We also retrospectively analyzed the incidence of severe anastomotic leakage in 194 patients who underwent colorectal anastomosis using a double- or triple-layered circular stapler during rectal cancer resection performed in two cancer centers between January 2015 and April 2021. Results: In the porcine model, the bursting pressure was higher in anastomoses created using the triple-layered stapler than the double-layered stapler (end-to-end anastomosis: 26.4 ± 6.2 mm Hg vs 14.5 ± 4.3 mm Hg, P =.0031; side-to-side anastomosis: 27.7 ± 5.0 mm Hg vs 18.0 ± 2.9 mm Hg, P =.0275). Intersectional leakage occurred in 41% and 83% of anastomoses created using the triple- or double-layered stapler, respectively (P =.0821). In the clinical cohort, the double- and triple-layered stapler was used in 153 and 41 patients, respectively. The incidence of anastomotic leakage was lower for anastomoses created using the triple-layered stapler vs the double-layered stapler (0.0% vs 5.8%, P =.0362). In multivariate analysis, the factors independently associated with a lower incidence of anastomotic leakage were female sex (odds ratio: 0.16, 95% confidence interval: 0.01-0.90, P =.0354) and triple-layered stapler usage (odds ratio: 0.00, 95% confidence interval: 0.00-0.96, P =.0465). Conclusion: Anastomoses created using a triple-layered circular stapler had high bursting pressure, which might contribute to a lower incidence of anastomotic leakage after rectal cancer surgery.

    DOI: 10.1002/ags3.12516

    Web of Science

    Scopus

    PubMed

  • Plasma-informed minimal residual disease (MRD) assay: A multicenter prospective study in Japanese patients with stage II colorectal cancer 査読 国際誌

    Oki, E; Ando, K; Hisamatsu, Y; Nakanishi, R; Nakaji, Y; Kudou, K; Kusumoto, T; Kagawa, Y; Ung, WC; Niiro, H; Tada, S; Hirose, T

    JOURNAL OF CLINICAL ONCOLOGY   40 ( 4 )   2022年2月   ISSN:0732-183X eISSN:1527-7755

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1200/JCO.2022.40.4_suppl.161

    Web of Science

  • PRKRIP1,a factor of splicing complex, on chromosome 7q may be a novel Prognostic factors in colorectal cancer 査読 国際誌

    Ozato, Y; Masuda, T; Kobayashi, Y; Takao, S; Hisamatsu, Y; Toshima, T; Yonemura, Y; Mizushima, T; Mori, M; Eguchi, H; Doki, Y; Mimori, K

    CANCER SCIENCE   113   600 - 600   2022年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • High expression of the glycolytic enzyme gene PGK1 is a prognostic factor in esophageal cancer 査読 国際誌

    Saito, H; Masuda, T; Mochizuki, K; Abe, T; Ozato, Y; Ando, Y; Nakano, T; Motomura, Y; Koike, K; Takahashi, J; Hisamatsu, Y; Toshima, T; Yonemura, Y; Saeki, H; Mimori, K

    CANCER SCIENCE   113   1196 - 1196   2022年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • Clinical significance of SETBP1 expression in breast cancer. 査読 国際誌

    Ando, Y; Masuda, T; Hayashi, N; Mochizuki, K; Abe, T; Saito, H; Ozato, Y; Nakano, T; Koike, K; Motomura, Y; Takahashi, J; Toshima, T; Hisamatsu, Y; Yonemura, Y; Mimori, K

    CANCER SCIENCE   113   741 - 741   2022年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • FANCE, one of the Fanconi anemia (FA) pathway genes, could be a potential therapeutic target for HCC. 査読 国際誌

    Takahashi, J; Masuda, T; Kitagawa, A; Ozato, Y; Nakano, T; Kosai, K; Kobayashi, Y; Koike, K; Motomura, Y; Ando, Y; Toshima, T; Hisamatsu, Y; Yonemura, Y; Yoshizumi, T; Mimori, K

    CANCER SCIENCE   113   950 - 950   2022年2月   ISSN:1347-9032 eISSN:1349-7006

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Web of Science

  • The effects of ARID1A mutations on colorectal cancer and associations with PD-L1 expression by stromal cells 査読 国際誌

    Kamori, T; Oki, E; Shimada, Y; Hu, QJ; Hisamatsu, Y; Ando, K; Shimokawa, M; Wakai, T; Oda, Y; Mori, M

    CANCER REPORTS   5 ( 1 )   e1420   2022年1月   eISSN:2573-8348

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Cancer Reports  

    Background: ARID1A is a component of the SWI/SNF complex, which controls the accessibility of proteins to DNA. ARID1A mutations are frequently observed in colorectal cancers (CRCs) and have been reported to be associated with high mutational burden and tumor PD-L1 expression in vitro. Aim: To clarify the role of ARID1A mutation in CRC. Method and results: We used next generation sequencing (NGS) and immunohistochemistry on clinically obtained samples. A total of 201 CRC tissues from Niigata University and Niigata Center Hospital were processed by NGS using the CANCERPLEX panel. Immunohistochemistry for ARID1A, PD-L1, MLH1, and MSH2 was performed on 66 propensity-matched (33 microsatellite instability-high [MSI-H] and 33 microsatellite-stable [MSS]) cases among 499 cases from Kyushu University. TCGA data were downloaded from cBioPortal. NGS showed significantly more mutations in ARID1A mutated CRCs (p = 0.01), and the trend was stronger for right-sided CRCs than left-sided. TCGA data confirmed these findings (p < 0.01). BRAF V600E and ATM mutations were also found at higher frequencies. Immunohistochemistry showed that 30% of MSI-H CRCs had ARID1A loss, while this was true in only 6% of MSS CRCs. In both MSI-H and MSS, PD-L1 expression by stromal cells was enhanced in the ARID1A-mutant groups (90% vs 39% in MSI-H, 100% vs 26% in MSS). Conclusion: We found a higher mutational burden in ARID1A-mutant CRCs, and IHC study showed that ARID1A loss was correlated with high PD-L1 expression in stromal cells regardless of MSI status. These data support the idea that mutant ARID1A is a potential biomarker for CRCs.

    DOI: 10.1002/cnr2.1420

    Web of Science

    Scopus

    PubMed

  • 特発性門脈血栓症によって生じた小腸壊死への手術後に致死的肺塞栓症が認められた症例 症例報告(Fatal pulmonary embolism after surgery for small intestinal necrosis caused by idiopathic portal vein thrombosis: a case report) 査読 国際誌

    Iwasaki Hitoshi, Uehara Hideo, Fujimoto Yugo, Hasuda Hirofumi, Kusumoto Eiji, Hisamatsu Yuichi, Yoshida Rintaro, Sakaguchi Yoshihisa, Kusumoto Tetsuya

    Surgical Case Reports   10   s40792 - 024   2024年4月

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:(一社)日本外科学会  

    症例は69歳女性。特記すべき既往歴はなかったが、7日前からの上腹部不快感が続くため来院した。身体所見では軽度の腹部膨満と右下腹部の圧痛を認め、血液検査で総白血球数上昇とCRP上昇が明らかになった。腹部造影CTで門脈血栓症(PVT)と腸間膜静脈血栓症、肝門部のcavernous transformationを認め、小腸ループの造影は不良であった。PVTの危険因子はなく、特発性PVTによる腸管壊死と診断し、緊急手術を行った。回腸の末端30cmは赤黒く変色しており、腸管壊死を示していた。壊死部を切除し、切除標本の病理学的検査ではうっ血と浮腫を伴う全周性の粘膜壊死が認められた。術後2日目に呼吸困難となり、心肺停止となった。心肺蘇生により一旦は回復したが、肺塞栓症が明らかになったため、直ちにV-A ECMOと抗凝固療法を開始した。2日後、V-A ECMOから離脱し、抗凝固療法を継続した。その後、神経学的障害を残すことなく回復し、術後26日目に退院した。

▼全件表示

講演・口頭発表等

  • 75歳以上の高齢者直腸癌に対する腹腔鏡下手術の安全性の検討

    久松 雄一, 藤岡 雄介, 蓮田 博文, 中西 良太, 楠元 英次, 上原 英雄, 杉山 雅彦, 吉田 倫太郎, 沖 英次, 山本 学, 坂口 善久, 楠本 哲也

    日本外科学会定期学術集会抄録集  2024年4月  (一社)日本外科学会

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 直腸癌の治療戦略 TNTから最近の話題まで

    久松 雄一, 安東 由貴, 廣瀬 皓介, 戸島 剛男, 米村 祐輔, 増田 隆明, 三森 功士

    日本臨床外科学会雑誌  2022年12月  日本臨床外科学会

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 神経線維腫症1型と鑑別が困難であったGIST腹膜播種の1切除例

    久松 雄一, 安東 由貴, 戸島 剛男, 米村 祐輔, 増田 隆明, 三森 功士

    日本臨床外科学会雑誌  2022年2月  日本臨床外科学会

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 胃原発mixed adenoneuroendocrine carcinomaの3例の検討

    久松 雄一, 藤岡 雄介, 蓮田 博文, 楠元 英次, 上原 英雄, 吉田 倫太郎, 坂口 善久, 楠本 哲也

    日本胃癌学会総会記事  2024年2月  (一社)日本胃癌学会

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 閉塞性大腸癌に対する大腸ステント留置の意義 bridge to surgeryの観点から

    久松 雄一, 安東 由貴, 高橋 純一, 戸島 剛男, 米村 祐輔, 増田 隆明, 三森 功士

    日本外科学会定期学術集会抄録集  2022年4月  (一社)日本外科学会

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

  • 乳癌治療における腋窩郭清の再考:術前化学療法後の腋窩リンパ節転移消失因子の特定

    久松 雄一

    第125回 日本外科学会定期学術集会  2025年4月 

     詳細を見る

    開催年月日: 2025年4月

    記述言語:日本語   会議種別:口頭発表(一般)  

    国名:日本国  

  • 閉塞性大腸癌に対する大腸ステント留置の意義 -bridge to surgeryの観点から-

    久松雄一、安東由貴、高橋純一、戸島剛男、米村祐輔、増田隆明、三森功士

    第122回 日本外科学会定期学術集会  2022年4月 

     詳細を見る

    開催年月日: 2022年4月

    記述言語:日本語  

    国名:日本国  

  • StageIV胃癌に対してconversion surgeryを施行した4例の検討

    久松雄一, 藤本禎明, 城後友望子, 胡慶江, 鉾之原健太郎, 中西良太, 安藤幸滋, 木村和恵, 沖英次, 森正樹

    2021年7月 

     詳細を見る

    開催年月日: 2021年7月

    記述言語:日本語  

    国名:日本国  

▼全件表示

共同研究・競争的資金等の研究課題

  • 空間的シングルセル解析による大腸腺腫から発がん過程に於ける免疫寛容獲得機構の解明

    研究課題/領域番号:23K08074  2023年4月 - 2026年3月

    科学研究費助成事業  基盤研究(C)

    久松 雄一, 三森 功士, 坂本 毅治, 胡 慶江

      詳細を見る

    担当区分:研究代表者  資金種別:科研費

    前がん病変から早期がんにおけるVISIUMの解析結果より、発がん過程においてがん微小環境(腫瘍免疫応答)は如何に関与するか?解明する。すなわち大腸腺腫、早期大腸がん病変と間質細胞(免疫担当細胞など)の発現遺伝子プロファイルを時空間的にシングルセルレベルで解析し3者間で比較検討することで、腺腫から癌細胞への進展を幇助する可能性を示す遺伝子を同定する。特に発がん過程で免疫寛容の獲得に寄与しうる「腺腫に局在する腫瘍免疫応答関連細胞由来の遺伝子」を同定し治療標的としての意義を明らかにする。

    CiNii Research

教育活動概要

  • 消化管外科・乳腺外科のスタッフとして、大学院生の研究と論文指導に従事している。大学院生に研究のテーマを深く理解し、その研究で得られた結果が今後の治療にどのように活かせるのかを常に考察することを指導している。

その他教育活動及び特記事項

  • 2021年  その他特記事項  大学院生の研究について、そのノウハウや得られた結果についての考察をともに行い、論文作成の指導を行っている。

     詳細を見る

    大学院生の研究について、そのノウハウや得られた結果についての考察をともに行い、論文作成の指導を行っている。

その他部局等における各種委員・役職等

  • 2022年4月 - 2026年3月   その他 安全管理委員会の委員

社会貢献・国際連携活動概要

  • 【学会発表】
    1. 第125回 日本外科学会定期学術集会
    乳癌治療における腋窩郭清の再考:術前化学療法後の腋窩リンパ節転移消失因子の特定
    一般演題
    久松雄一、池田俊司、吉田百合絵、大森幸恵、吉住朋晴
    2025年 4 月 10 -12 日 
    仙台(仙台国際センター)

社会貢献活動

  • 学外の講師や准教授の方や研究者の方に対して、自分の研究成果を発表し、情報を共有している。

    2022年4月 - 2026年3月

     詳細を見る

    学外の講師や准教授の方や研究者の方に対して、自分の研究成果を発表し、情報を共有している。

専門診療領域

  • 生物系/医歯薬学/外科系臨床医学/消化管外科学